Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,550
datasets available to search
ShareScore release 0.7.1
Dataset results
2,550 results for “Glioblastoma”
Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
ClinicalTrials.gov study NCT01013285. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
ClinicalTrials.gov study NCT01648348. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma
ClinicalTrials.gov study NCT03661723. IPD Sharing: NO. Countries: 1. Publications: 0.
Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma
ClinicalTrials.gov study NCT02394665. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma
ClinicalTrials.gov study NCT03367715. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
ClinicalTrials.gov study NCT02315534. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov study NCT00590681. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)
ClinicalTrials.gov study NCT00735436. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM)
ClinicalTrials.gov study NCT02765165. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma
ClinicalTrials.gov study NCT00790452. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
ClinicalTrials.gov study NCT03347617. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma
ClinicalTrials.gov study NCT03430791. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Abemaciclib in Recurrent Glioblastoma
ClinicalTrials.gov study NCT02981940. IPD Sharing: NO. Countries: 1. Publications: 0.
Abemaciclib + Pembrolizumab In Glioblastoma
ClinicalTrials.gov study NCT04118036. IPD Sharing: YES. Countries: 1. Publications: 0.
Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
ClinicalTrials.gov study NCT04216329. IPD Sharing: YES. Countries: 1. Publications: 0.
Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma
ClinicalTrials.gov study NCT02478164. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
ClinicalTrials.gov study NCT02661282. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
ClinicalTrials.gov study NCT00387894. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma
ClinicalTrials.gov study NCT04116658. IPD Sharing: YES. Countries: 4. Publications: 0.
Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme
ClinicalTrials.gov study NCT00641706. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.